M&T Bank’s Amgen AMGN Stock Holding History

M&T Bank’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.7M	Sell	162,127 -3,052	-2%	-$1.04M	0.17%	110
2026 Q1	$58.1M	Sell	165,179 -5,819	-3%	-$2.07M	0.2%	100
2025 Q4	$56M	Buy	170,998 +128	+0.1%	+$40.6K	0.18%	102
2025 Q3	$48.2M	Sell	170,870 -60,616	-26%	-$17.6M	0.16%	112
2025 Q2	$64.6M	Sell	231,486 -61,355	-21%	-$17.4M	0.22%	88
2025 Q1	$91.2M	Sell	292,841 -13,632	-4%	-$4.03M	0.33%	66
2024 Q4	$79.9M	Sell	306,473 -6,763	-2%	-$2.01M	0.27%	76
2024 Q3	$101M	Sell	313,236 -18,026	-5%	-$5.9M	0.33%	65
2024 Q2	$104M	Sell	331,262 -2,456	-0.7%	-$722K	0.35%	61
2024 Q1	$94.9M	Buy	333,718 +615	+0.2%	+$180K	0.33%	66
2023 Q4	$95.9M	Sell	333,103 -3,972	-1%	-$1.08M	0.35%	67
2023 Q3	$90.6M	Sell	337,075 -8,396	-2%	-$2.1M	0.36%	65
2023 Q2	$76.7M	Sell	345,471 -5,316	-2%	-$1.23M	0.29%	82
2023 Q1	$84.8M	Sell	350,787 -3,130	-0.9%	-$768K	0.33%	74
2022 Q4	$92.9M	Buy	353,917 +1,213	+0.3%	+$325K	0.37%	67
2022 Q3	$79.5M	Buy	352,704 +2,401	+0.7%	+$582K	0.35%	68
2022 Q2	$79.8M	Buy	350,303 +20,956	+6%	+$5.14M	0.38%	66
2022 Q1	$79.6M	Buy	329,347 +31,769	+11%	+$7.3M	0.35%	71
2021 Q4	$66.9M	Buy	297,578 +1,207	+0.4%	+$255K	0.28%	83
2021 Q3	$63M	Sell	296,371 -1,267	-0.4%	-$292K	0.28%	84
2021 Q2	$72.5M	Sell	297,638 -6,493	-2%	-$1.6M	0.32%	77
2021 Q1	$75.7M	Sell	304,131 -22,716	-7%	-$5.42M	0.33%	74
2020 Q4	$75.2M	Sell	326,847 -1,847	-0.6%	-$426K	0.33%	71
2020 Q3	$83.5M	Sell	328,694 -5,451	-2%	-$1.35M	0.41%	57
2020 Q2	$78.8M	Sell	334,145 -6,824	-2%	-$1.56M	0.42%	55
2020 Q1	$69.1M	Sell	340,969 -8,327	-2%	-$1.82M	0.41%	56
2019 Q4	$84.2M	Buy	349,296 +194	+0.1%	+$42.8K	0.4%	44
2019 Q3	$67.6M	Sell	349,102 -10,207	-3%	-$1.96M	0.34%	76
2019 Q2	$66.2M	Sell	359,309 -4,361	-1%	-$781K	0.35%	78
2019 Q1	$69.1M	Sell	363,670 -9,623	-3%	-$1.84M	0.36%	70
2018 Q4	$72.7M	Sell	373,293 -2,469	-0.7%	-$482K	0.42%	52
2018 Q3	$77.9M	Sell	375,762 -15,108	-4%	-$2.98M	0.39%	60
2018 Q2	$72.2M	Buy	390,870 +4,836	+1%	+$855K	0.39%	63
2018 Q1	$65.8M	Sell	386,034 -29,159	-7%	-$5.35M	0.35%	70
2017 Q4	$72.2M	Buy	415,193 +69,371	+20%	+$12.3M	0.38%	69
2017 Q3	$64.5M	Sell	345,822 -6,683	-2%	-$1.18M	0.35%	75
2017 Q2	$60.7M	Buy	352,505 +5,336	+2%	+$868K	0.36%	73
2017 Q1	$57M	Sell	347,169 -14,456	-4%	-$2.4M	0.34%	81
2016 Q4	$52.9M	Buy	361,625 +2,361	+0.7%	+$355K	0.33%	84
2016 Q3	$59.9M	Sell	359,264 -638	-0.2%	-$108K	0.38%	66
2016 Q2	$54.8M	Buy	359,902 +5,224	+1%	+$812K	0.37%	69
2016 Q1	$53.2M	Sell	354,678 -15,528	-4%	-$2.31M	0.36%	72
2015 Q4	$60.1M	Sell	370,206 -1,833	-0.5%	-$288K	0.4%	62
2015 Q3	$51.5M	Buy	372,039 +24,487	+7%	+$3.86M	0.35%	70
2015 Q2	$53.4M	Sell	347,552 -1,283	-0.4%	-$206K	0.32%	70
2015 Q1	$55.8M	Buy	348,835 +8,653	+3%	+$1.36M	0.35%	63
2014 Q4	$54.2M	Buy	340,182 +10,215	+3%	+$1.59M	0.34%	61
2014 Q3	$46.3M	Buy	329,967 +224,851	+214%	+$29.4M	0.3%	69
2014 Q2	$12.4M	Sell	105,116 -32,582	-24%	-$3.77M	0.52%	43
2014 Q1	$17M	Sell	137,698 -948	-0.7%	-$115K	0.7%	32
2013 Q4	$15.8M	Sell	138,646 -5,488	-4%	-$624K	0.66%	34
2013 Q3	$16.1M	Sell	144,134 -2,154	-1%	-$234K	0.77%	31
2013 Q2	$14.4M	Buy	+146,288	New	+$15.2M	0.7%	34

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

M&T Bank's AMGN Position: Q2 2026 in Review

M&T Bank reduced its Amgen (AMGN) stake by 1.8% in Q2 2026, selling an estimated $1.04M and leaving 162,127 shares worth $58.7M. The position accounts for 0.17% of the portfolio, ranked #110.

M&T Bank first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $104M in Q2 2024. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

M&T Bank held 162,127 shares of Amgen worth $58.7M as of Q2 2026.
M&T Bank sold 3,052 Amgen shares in Q2 2026, an estimated $1.04M.
Amgen made up 0.17% of M&T Bank's portfolio in Q2 2026, its #110 holding.
M&T Bank first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
M&T Bank's Amgen position peaked at $104M in Q2 2024.
3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.